Reported Friday, "Tharimmune Enters ATM Agreement With Rodman & Renshaw To Sell Common Stock At Market Price, Paying 3% Commission On Sales"
Portfolio Pulse from Benzinga Newsdesk
Tharimmune has entered into an At-The-Market (ATM) agreement with Rodman & Renshaw to sell its common stock at market price, with a 3% commission on sales.
June 10, 2024 | 4:03 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Tharimmune has entered into an ATM agreement with Rodman & Renshaw to sell its common stock at market price, paying a 3% commission on sales. This could lead to increased stock liquidity but may also put downward pressure on the stock price due to potential dilution.
The ATM agreement allows Tharimmune to sell additional shares at market price, which can increase liquidity. However, the issuance of new shares can dilute existing shareholders' value, potentially putting downward pressure on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100